CITIUS PHARMAC Financials

CITIUS PHARMAC Stock Summary

CITIUS PHARMAC competes with FARO Technologies, ACCSYS TECHPLC, Axcelis Technologies, AAC TECHNOLOGHLDGADR, and Playtech Plc. Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products targeting medical needs with a focus on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. CITIUS PHARMAC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10 people.

CITIUS PHARMAC Key Financial Ratios

There are many critical financial ratios that CITIUS PHARMAC's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CITIUS PHARMAC DL reports annually and quarterly.

CITIUS Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CITIUS PHARMAC's current stock value. Our valuation model uses many indicators to compare CITIUS PHARMAC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CITIUS PHARMAC competition to find correlations between indicators driving CITIUS PHARMAC's intrinsic value. More Info.CITIUS PHARMAC DL is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CITIUS PHARMAC's earnings, one of the primary drivers of an investment's value.

CITIUS PHARMAC DL Systematic Risk

Along with financial statement analysis, the daily predictive indicators of CITIUS PHARMAC help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CITIUS PHARMAC DL. We use our internally-developed statistical techniques to arrive at the intrinsic value of CITIUS PHARMAC DL based on widely used predictive technical indicators. In general, we focus on analyzing CITIUS Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CITIUS PHARMAC's daily price indicators and compare them against related drivers.

When running CITIUS PHARMAC's price analysis, check to measure CITIUS PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CITIUS PHARMAC is operating at the current time. Most of CITIUS PHARMAC's value examination focuses on studying past and present price action to predict the probability of CITIUS PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CITIUS PHARMAC's price. Additionally, you may evaluate how the addition of CITIUS PHARMAC to your portfolios can decrease your overall portfolio volatility.